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https://doi.org/10.1016/j.celrep.2020.108004SUMMARYDuring embryogenesis, lymphoid tissue inducer (LTi) cells are essential for lymph node organogenesis.
These cells are part of the innate lymphoid cell (ILC) family. Although their earliest embryonic hematopoietic
origin is unclear, other innate immune cells have been shown to be derived from early hemogenic endothe-
lium in the yolk sac as well as the aorta-gonad-mesonephros. A proper model to discriminate between these
locations was unavailable. In this study, using a Cxcr4-CreERT2 lineage tracing model, we identify a major
contribution from embryonic hemogenic endothelium, but not the yolk sac, toward LTi progenitors.
Conversely, embryonic LTi cells are replaced by hematopoietic stem cell-derived cells in adults. We further
show that, in the fetal liver, common lymphoid progenitors differentiate into highly dynamic alpha-lymphoid
precursor cells that, at this embryonic stage, preferentially mature into LTi precursors and establish their
functional LTi cell identity only after reaching the periphery.INTRODUCTION
The innate lymphoid cell (ILC) family was recognized about 10
years ago (Vivier et al., 2018) and is considered the innate
counterpart of T lymphocytes but without antigen receptor re-
arrangement. ILC type 3 (ILC3) is characterized by expression
of the nuclear transcription factor retinoic acid receptor-related
orphan receptor variant gt (RORgt), which is encoded by the
gene Rorc and is mostly associated with gut and skin immunity
(Rankin et al., 2016). Initially characterized as an ILC3 subtype,
lymphoid tissue inducer (LTi) cells are the first ILC family mem-
bers observed during life and are critically involved in lymph
node (LN) formation within the embryo (van de Pavert and Me-
bius, 2010; van de Pavert and Vivier, 2016; van de Pavert et al.,
2014). The earliest described LTi progenitor is the common
lymphoid progenitor (CLP) stage, which, through the alpha-
lymphoid precursor (aLP) stage, differentiates toward LTi pre-
cursors (LTiPs) and, subsequently, into RORgt+ LTi0 cells
(Chea et al., 2016; Ishizuka et al., 2016b, 2016a; van de Pavert
et al., 2014). LTi4 cells are the final stage in LTi ontogeny and
additionally express CD4, TNF-related activation-induced cyto-
kine (TRANCE, also known as tumor necrosis factor ligand su-
perfamily member 11 [TNFSF11] or receptor activator of nu-
clear factor kappa B ligand [RANKL]), and lymphotoxin-abThis is an open access article under the CC BY-N(van de Pavert et al., 2014) to facilitate interaction with mesen-
chymal lymphoid tissue organizer (LTo) cells within LN anlagen
via the lymphotoxin receptor pathway. This amplifies expres-
sion of chemokines, cytokines, and retention molecules from
LTo cells to attract and retain more LTi cells (van de Pavert
and Mebius, 2010; Vondenhoff et al., 2009). LN formation starts
with clustering of LTi cells with LTo cells, initially without lym-
photoxin signaling, at embryonic day 12.5 (E12.5) (van de Pa-
vert et al., 2009; Veiga-Fernandes et al., 2007). After E14.5, a
dramatic increase in LN anlagen size can be observed because
of activation of the lymphotoxin signaling pathway (van de Pa-
vert and Mebius, 2010).
The hematopoietic source of CLPs is currently unknown.
The earliest hematopoietic cells are generated by special
endothelial cells, called hemogenic endothelial cells, located
in the extra-embryonic yolk sac (YS) or in embryonic regions,
of which the aorta-gonad-mesonephros (AGM) region is the
most-studied region, that transition into hematopoietic pro-
genitor cells (Boisset et al., 2010; Lancrin et al., 2009). It has
been shown that the first hematopoietic progenitors appear
from the YS and include, e.g., microglia, erythroid-myeloid
progenitors, neutrophils, and mast cells, whereas later line-
ages and hematopoietic stem cells (HSCs) appear from the
AGM at later time points (Gentek et al., 2018; Mass et al.,Cell Reports 32, 108004, August 11, 2020 ª 2020 The Authors. 1
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Quantification of LN Formation in
Whole-Mount E12.5–E14.5 Embryos
Whole RORgteGFP embryos were analyzed at
E12.5–E14.5 by light sheet microscopy.
(A–C) Projections of the light sheet analysis of
RORgt+ (red) and CD4+ (cyan) cells in the different
LN anlagen from the right half of the whole mount
RORgteGFP embryos at (A) E12.5, (B) E13.5, and (C)
E14.5. For orientation purposes, neurons were
visualized by bIII-tubulin (green). Using the spot-
function tool in Imaris, we annotated these cells as
spots, which were subsequently quantified. There
is staining within the sac around the heart, most
likely not LTi cells because of their size. Embryos
are orientated with the head up, dorsal side at the
left, and ventral to the right. CLN, cervical lymph
node; MdLN, mandibular LN; BrLN, brachial LN;
AxLN, axillary LN; RenLN, renal LN; IngLN, inguinal
LN anlagen. Scale bars, 500 mm.
(D) Quantification of LTi0 and LTi4 cells within the
LN anlagen over time in embryonic gestation,
based on the number of CD4+ (LTi4) spots and
RORgt+ minus the CD4+ spots (LTi0).
Data shown are averages ± SD; all data are based
on at least 2 independent experiments. See also
Figures S1A and S1B and Videos S1, S2, and S3.
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quently, most hematopoietic progenitors migrate to the fetal
liver (FL) to expand and differentiate toward precursors stages
of their respective lineages. Coming from the FL, HSCs
migrate via the embryonic spleen to colonize the bone marrow
around E16.5 and, during adulthood, are responsible for
continuous replacement of definitive hematopoietic lineages
(Gao et al., 2018). Although ILC progenitors have been shown
to be generated from HSCs in the bone marrow, formation of
LTi cells from HSCs has not yet been shown (Seillet et al.,
2016; Walker et al., 2019; Xu et al., 2019). When LTi progeni-
tors differentiate from the hemogenic endothelium and
whether they would appear concomitantly with HSCs is still
unknown. In addition, LTi cell differentiation pathways occur-2 Cell Reports 32, 108004, August 11, 2020ring in the FL and at which stage in their
ontogeny LTi cells colonize the embry-
onic periphery remains unclear.
In this study, we were able to discrim-
inate between the appearance of he-
matopoietic progenitors from the YS
and early embryonic hematopoietic
regions using a lineage tracing model.
Specifically, we show the complete
ontogeny and respective locations of
LTi cells, from their first appearance at
the hemogenic endothelium to formation
of LNs in the embryo. Multiple experi-
mental approaches collectively show
the importance of the FL in the expan-
sion and differentiation of LTiPs before
LTi cells colonize the embryonic
periphery. Finally, we demonstrate thatembryonic LTi cells are replaced in adult lymphoid tissues by
HSC-derived cells.
RESULTS
Visualization of LN Formation in Whole-Mount Embryos
To comprehensively study embryonic LN formation, we first
used whole-mount 3D immunofluorescence on E11.5–E14.5
RORgtEGFP embryos. We separately quantified LTi0 and LTi4
populations within all LN anlagen using the spotfunction tool in
Imaris (Figures 1A–1D, S1A, and S1B; Videos S1, S2, and S3).
Although we did not observe any LTi cells in E11.5 RORgteGFP
embryos (data not shown), clusters of LTi0 cells (RORgt
+ cells)
and LTi4 (RORgt
+CD4+) cells started to appear at E12.5 (Figures
Article
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OPEN ACCESS1A and S1A; Video S1). At this stage, small LTi0 clusters as well
as the presumptive cervical LN (CLN) anlagen and mandibular
LN (MdLN) anlagen were located very close to each other in
the cervical region. A second cluster could also be observed in
the axillary region but not yet the separate brachial LN (BrLN)
anlagen and axillary LN (AxLN) anlagen. Finally, a third cluster
was present near the mesonephros, which we identified as the
renal LNs (RenLNs). Interestingly, we found numerous
RORgt+CD4– cells within the nasal cavity (arrowhead in Fig-
ure 1A), possibly involved in formation of nasal-associated
lymphoid tissues during later gestation. At E13.5 (Figures 1B
and S1A; Video S2), LTi0 and LTi4 cells further accumulate and
allow identification of the cLN and MdLN anlagen within the cer-
vical region. However, despite the presence of an LTi cluster
close to the skin in the axillary region, the AxLN and BrLN
anlagen still could not be clearly discriminated. Also, because
of scattered RORgt+ and CD4+ cells within the gut and spleen,
it was not possible to discriminate between stretched mesen-
teric LN anlagen and intestinal ILCs. By E14.5 (Figures 1C and
S1A; Video S3), most peripheral LN anlagen (CLNs, MdLNs,
AxLNs, BrLNs, RenLNs, and inguinal LNs [IngLNs]) could be
identified and counted using Imaris, whereas the popliteal LNs
(PopLNs) were still very small (Figures 1C, 1D, S1A, and S1B).
LTi0 and LTi4 Cells Are Mainly Present within the
Periphery
After quantification of the LTi0 and LTi4 cells that formed the LN
anlagen within the periphery, we set out to quantify all popula-
tions described within the LTi ontogeny. We used RORgtEGFP
embryos between E11.5 and E14.5 and analyzed these popula-
tions within the FL and embryonic periphery using flow cytome-
try. Because it was not possible to distinguish between aLP and
LTiP in flow cytometry, we used the annotation LTiP for this stage
for all of our flow cytometry data. We observed that all popula-
tions increased during embryonic stages (Figures 2A–2C and
numbers in Figure S2B). Further, although the CLPs were mostly
present in the FL, similar numbers of LTiP cells were recovered
from the periphery and the FL, and LTi0 and LTi4 cells were de-
tected primarily within the periphery.
The marked increase in LTi cells between E13.5 and E14.5
suggested increased cell influx and/or increased local
proliferation. To understand this phenomenon, we performed a
5-ethynyl-20-deoxyuridine (EdU) assay at E13.5. We observed
that proliferation was similar in CLPs obtained from the FL and
periphery (Figure 2D). Themost proliferative cells were LTiP cells
obtained from the FL, whereas proliferation was lower in periph-
eral LTiP cells. LTi cells showed the lowest proliferation, espe-
cially in the periphery. These data suggest that the increase of
LTi cells at E14.5 is primarily due to proliferation of CLP and
especially LTiP cells in the FL and, thus, that the increase in LN
anlagen was due to increased LTiP influx.
Transcriptional Expression Profiling of the LTi Ontogeny
in FL versus the Periphery
To study whether there is a correlation in LTi ontogeny within the
FL toward LTi cells in the periphery, we sort-purified the popula-
tions involved in LTi ontogeny from both tissues and compared
their transcription expression profiles by bulk RNA sequencing.The populations isolated from the FL and periphery were CLP,
LTiP, LTi0 and LTi4. In the principal-component analysis (PCA)
comparison, the CLP and LTiP populations highly segregated
against the LTi0 and LTi4 populations (Figures 3A and 3B), inde-
pendent of tissue origin. The similarities in gene expression
within the LTi0 and LTi4 populations were high, including ILC3-
associated genes such as Il22 and Il17a (highlighted in Fig-
ure 3B). Also, Rxrg, a retinoic acid receptor, was expressed by
LTiP, LTi0, and LTi4 populations (highlighted in Figure 3B), sug-
gesting that LTiP cells became responsive to retinoic acid, which
has been shown to be required for the next step in differentiation
(van de Pavert et al., 2014). We observed the largest segregation
between the LTiP and LTi0 populations (57% of observed vari-
ance; Figure 3C). The heatmap for these stages also combined
all LTi0 samples versus all LTiP samples, regardless of their origin
(Figure 3D). These data suggest that differentiation between LTiP
and LTi0 induced the largest variation. The segregation between
CLP and LTiP versus LTi0 and LTi4 cells, regardless of their
origin, was also observed when the best loading genes of each
axis were compared with all other populations in the correlation
matrix (Figure 3E). The blue clusters indicate a positive correla-
tion, which was observed in the LTiP/CLP stages versus the
LTi0/LTi4 stages, independent of tissue origin. Many LTi cell-
associated genes, such as LTb, Cxcr6, and S1pr1 (Figure 3F),
and transcription factors, such as Rorc and Tcf7 (Figure S3C),
were similarly upregulated in FL- and periphery-derived LTi cells.
Also, other gene expression patterns across the differentiation
stages, as shown in the evolution plots for cytokines (FigureS3D),
tumor necrosis factor (TNF)-associated genes (Figure S3E), or
Notch signaling-associated genes (Figure S3F), were almost
similar in FL versus peripherally obtained LTi cells. In summary,
the most distinguishing stage was between the LTiP and LTi0
stage, when Rorc (RORgt) expression established a LTi pheno-
type. Based on the very low number of LTi0 and LTi4 cells within
the FL (Figures 2A–2C), which had similar expression profiles as
peripheral LTi cells, we propose that LTi0 and LTi4 cells differen-
tiate in the periphery from LTiP cells.
Single-Cell Sequencing Revealed that CLPs
Preferentially Differentiate into ILC3 and LTi Cells
within the Periphery at E13.5
To better understand the steps involved in LTi differentiation
within the embryonic periphery, we performed single-cell
sequencing analysis on CD45+Lin–F4/80–Il7Ra+ cells obtained
from E13.5 and E14.5 FL and embryonic periphery (for gating
of the populations, see Figure S4). After normalization, quality
control, and removal of clusters of residual macrophages
(Cx3cr1), pre-mature B cells (CD79a), and mast cells (Oms) for
analysis, we used 2,715 cells from E13.5 periphery, 2,978 cells
from E14.5 periphery, 6,616 cells from E13.5 FL, and 2,034 cells
from E14.5 FL. In the FL, about half of the cells were clustered
because of genes associated with proliferation, indicating a
switch between a proliferative state and differentiation at each
stage (Figures S5B and S5D). Even though we excluded macro-
phages by Cx3cr1 and pro-B cells by CD79a, we still observed
some clearly separated clusters in the FL (9 and 13 at E13.5
and 10 and 11 at E14.5; Figure S5), which could be monocyte-
or B cell-fated cells.Cell Reports 32, 108004, August 11, 2020 3
Figure 2. Analysis of the Populations in LTi
Ontogeny
(A and B) Representative flow cytometry plots of
LTi ontogeny at embryonic stages E11.5–E14.5
from RORgteGFP embryos in the FL (A) and em-
bryonic periphery (B), enriched for the peripheral
LN anlagen. CLPs are defined as CD45+F4/
80–IL7Ra+a4b7
–RORgt–CD4– cells, LTiPs as
CD45+F4/80–IL7Ra+a4b7
+RORgt–CD4– cells, LTi0
as CD45+F4/80–IL7Ra+a4b7
+RORgt+CD4– cells,
and LTi4 as CD45
+F4/80–IL7Ra+a4b7
+RORgt+
CD4+ cells. The numbers shown in the plots are
average percentages for each population. For the
gating strategy, see Figure S2A. Numbers are
shown in the table in Figure S2B.
(C) Graphical representation showing the average
cell counts ± SD of flow cytometry in time. Cell
counts represent absolute cell numbers present in
each tissue and were obtained by multiplying the
percentage of the total for each cell subtype
multiplied by the total number of cells counted
before staining.
(D) Proliferation of the LTi populations within E13.5
RORgteGFP embryos in the FL and periphery by
flow cytometry 2 h after EdU injection in a pregnant
mouse. LTi cells are defined as CD45+F4/80–
IL7Ra+a4b7
+RORgt+ and include LTi0 and LTi4. For
the gating strategy, see Figure S2C.
Data shown are from at least two independent
experiments and are shown as average ± SD.
Single data points in (D) represent individual em-
bryos.
Article
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OPEN ACCESSUsing flow cytometry, it was impossible to delineate aLPs from
LTiPs (both being Il7Ra+, a4b7+RORgt–; Figure 2). However, us-
ing single-cell sequencing, wewere able to distinguish both pop-
ulations separately in the FL as Itga4+Id2+Cxcr5– aLPs (clusters4 Cell Reports 32, 108004, August 11, 20201, 3, and 8 at E13.5 and clusters 2 and 5 at
E14.5) and Cxcr5+ LTiP (clusters 10, 11,
and 12 at E13.5 and cluster 7 at E14.5)
(Figure S5), with most cells being aLPs
rather than LTiPs within the FL. Very few
cells were associated with LTi0 or LTi4
stages at E13.5 (Ccr6+ cells in cluster 11
at E13.5 and cluster 4 at E14.5). At
E13.5, analysis of differentiation using ve-
locity (La Manno et al., 2018) revealed
flow from aLPs toward LTiPs (from clus-
ter3 toward clusters 10 and 12; Fig-
ure S5C). At E14.5, however, velocity
directions were not strong from aLPs to-
ward LTi cells (within aLP cluster 2 toward
cluster 7; Figure S5G). Moreover, LTi
cluster 4 at E14.5 was completely sepa-
rated from the other LTi4 population.
Within the periphery, at E13.5, we
observed Flt3+Id2– CLP and Itga4+Id2+
aLP populations (clusters 6 and 10 and
partially in cluster 2; Figures 4A and 4B)
and substantially more LTiP cells. TheLTiP population showed expression of proliferation genes,
whereas LTi0 and LTi4 expressed genes associated with LTi
stages, such as Il22, Lta, and Cd4 (Figures 4B and S6). Prolifer-
ation is a strong nominator for clustering cells, showing about
Figure 3. Gene Expression Profiling of the Populations in LTi Ontogeny in FL versus Embryonic Periphery
Populations in LTi ontogeny were sort-purified from the FL (f) and periphery (e) of E13.5RORgteGFP embryos as f/e CLPs (Lin–CD45+IL7Ra+a4b7
–RORgt–CD4–), f/e
LTiPs (Lin–CD45+IL7Ra+a4b7
+RORgt–CD4–), f/e LTi0 (Lin
–CD45+IL7Ra+a4b7
+RORgt+CD4–), and f/e LTi4 (Lin
–CD45+IL7Ra+a4b7
+RORgt+CD4+). For the gating
strategies, see Figure S3A for FL and Figure S3B for embryonic periphery, enriched for peripheral LN anlagen.
(A) PCA of all populations from the FL and embryonic periphery. The largest variation is observed between CLPs and LTiPs versus LTi0 and LTi4, with 54% of the
total variance explained by PC1.
(B) Heatmap of gene expression of all LTi populations using the 30 best loading genes of the two first principal components of the PCA and hierarchical clustering
on rows and columns. We observed clustering based on stage in ontogeny rather than tissue of origin.
(C) PCA of LTiP and LTi0 populations from the FL and embryonic periphery. The largest variation is observed between LTiPs versus LTi0 independent of the tissue,
with 57% of the total variance explained by PC1.
(D) Heatmap of gene expression of all LTiP and LTi0 populations using the 30 best loading genes of the two first principal components of the PCA and hierarchical
clustering on rows and columns.
(E) Correlation matrix to quantify the differences or similarities between the populations and origin tissue based on the 30 best loading genes of each population.
(F) Evolutionary gene pattern expression plots of the separate populations based on the bulk sequencing data, with specific gene expression in the different
stages of LTi ontogeny in the periphery showing LTi-associated genes in the embryonic periphery or FL. See also Figures S3C–S3F.
Data shown are based on at least 2 independent flow cytometry sorts and experiments. FL fCLP, fLTiP, and fLTi0, n = 3; fLTi4, n = 2; embryonic peripheral cells
(eCLP, eLTiP, eLTi0, and eLTi4), n = 4.
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OPEN ACCESShalf of the Flt3+Id2– CLPs in proliferation (cluster 10) and the LTiP
population (cluster 4), supporting the proliferation assay results
(Figure 2D). Cluster 2 was a mix of non-proliferative aLP and
LTiP cells, based on partial expression of Cxcr6 and Cxcr5 (Fig-
ures 4B and S6). Using velocity, we observed a differentiationfrom CLP-aLP toward LTiP cells (cluster 2). Cluster 8 could be
a different source for ILC-precursor (ILCp) and LTiP cells, being
a separate source of progenitors other than cluster 6 (Figures 4A
and 4C), and this cluster was connected to proliferative LTiP
cluster 4. Besides the regular LTi-associated genes (FiguresCell Reports 32, 108004, August 11, 2020 5
Figure 4. Single-Cell Sequencing of the
Il7Ra+ Population at E13.5 and E14.5
(A–F) Alive CD45+F4/80–Il7Ra+ cells from E13.5
and E14.5 C57BL/6J embryo peripheries were
sort-purified by flow cytometry, and a library of
single-cell expression was generated using the
10x Genomics dropseq protocol. For the gating
strategy, see Figures S4A and S4B for the pe-
riphery and Figures S4C and S4D for the FL. For
single-cell results on FL, see Figures S5A–S5D for
the E13.5 stage and Figures S5E–S5H for the
E14.5 stage. E13.5 peripheral cells are shown in
(A)–(C), whereas E14.5 is shown in (D)–(F).
(A and D) UMAP plot showing the cell clusters.
(B and E) Gene expression UMAP plots for popu-
lation-annotated genes, listed per population.
Violin plots of these genes, showing more detail
regarding expression level and number of positive
cells per cluster, are shown in Figure S6A for E13.5
and in Figure S7A for E14.5. The 10 most changed
genes are shown in a heatmap in Figure S6B and in
Figure S7B for E14.5.
(C and F) RNA velocity analysis (La Manno et al.,
2018) based on the ratio of high nuclear RNA and
processed RNA, allowing analysis of the direction
of cell differentiation and aiding with determination
of the populations.
Article
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OPEN ACCESS4B, S6A, and S6B) in cluster 9, we also saw higher expression of
major histocompatibility complex MHC) class II-associated
genes, such as H2-Ab1 (see the heatmap in Figure S6B). On
the contrary, H2-Ab1 expression was less pronounced in LTi4
cluster 1. At E14.5, the most notable difference was the lack of
CLPs within the periphery but still observed in the FL. It is
likely that Il7Ra+a4b7
– cells observed in flow cytometry (Fig-
ure 2B) mostly represent non-ILC commmitted CLPs. Also, an6 Cell Reports 32, 108004, August 11, 2020Itga4+Id2+Cxcr6– aLP cluster was not
observed, based ongene expression (Fig-
ures 4D, 4E, S7A and S7B) and velocity
analysis (Figure 4F). We observed a LTiP
population (proliferating cluster 5, non-
proliferative in cluster 2) and 2 LTi0 and
LTi4 clusters. Besides lacking ILC-
committed CLPs and aLP, E14.5 clusters
resembled E13.5 but revealed more and
more distant LTi populations within the
Uniform Manifold Approximation and
Projection (UMAP) plot, such as the LTi4
population highly expressing H2-Ab1
and H2-Eb1 (cluster 8; Figures 4D, S6B,
and 7C). At E13.5 and E14.5, we did not
observe a natural killer (NK)-dedicated
(Eomes+) or ILC1-dedicated (Tbx21+
[Tbet]) cluster and few ILCp (Zbtb16+) or
ILC2 (Il13+Icos+) cells. All of these cells
were grouped together in cluster 5 at
E13.5 or cluster 6 at E14.5. ILC3 or LTi-
like cells were identified separately fromLTi cells, based onmuch lower Il23r,Ccr6,Cd4, and LTa expres-
sion levels and fewer positive cells within the clusters (3 and 7 at
E13.5 and 3, 4, and 10 at E14.5) (Figures 4A, S6A, and S7A). In
general, we identified most CLP and aLP cells within the FL and
most LTi cells within the periphery, confirming earlier flow cytom-
etry results. There is some ambiguity regarding the connection of
the LTiP, ILCp, and ILC3 clusters, possibly because of the previ-
ous described dynamic nature of ILC differentiation (Ishizuka
et al., 2016b; Walker et al., 2019). The main populations within
Figure 5. Hematopoietic Origin of LTi Cells
during Embryonic LN Formation
(A and B) Recombination within LTi4 cells (CD45
+F4/
80–IL7Ra+a4b7
+CD4+) in the periphery and LTi-like
cells (CD45+F4/80–IL7Ra+a4b7
+) in the FL from
E13.5 (A) iCdh5tdT pulsed with 4OHT between E7.5
and E10.5 and (B) iCxcr4tdT embryos pulsed with
4OHT between E8.5 and E10.5, measured by flow
cytometry. See the flow cytometry strategies in
Figures S8A–S8C.
(C) Immunofluorescence of fluorescent reporter
(tdT) recombination and CD4+ cells (green) in CLNs
or MdLNs from E13.5 iCdh5tdT embryos pulsed with
4OHT at E8.5 or E10.5 and iCxcr4tdT embryos
pulsed at E8.5 or E9.5. Arrows represent re-
combined CD4+ cells.
Scale bars, 40 mm. Data shown are from at least two
independent experiments and are shown as average
± SD. See also Figure S8D.
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OPEN ACCESSthis analysis are LTi cells rather than ILC1s or ILC2s, indicating
that, at this embryonic stage, aLPs in the FL and LTiPs in the pe-
riphery preferentially differentiate into LTi cells.
LTi Progenitors Are Generated from an Embryonic
Hemogenic Endothelial Site
Hematopoietic progenitors appear at specific time points from
the hemogenic endothelium in YS embryonic or hemogenic
endothelial sites, such as the AGM region. We first used Cdh5-
CreERT2+/;RosatdT (Gentek et al., 2018; Zovein et al., 2008)
(hereafter referred to as iCdh5tdT) as a lineage tracing model. In
this model, (hemogenic) endothelial cells from embryonic hemo-
genic sites or the YS and their respective hematopoietic progeny
undergo recombination to express tdTomato depending on
when 4-hydroxytamoxifen (4OHT) was injected. In general, YS
hemogenic endothelium is labeled when 4OHT is injected be-
tween E7.5 and E9, whereas the embryonic hemogenic endothe-
lium is labeled when injected between E8.5 and E11.5 (Gentek
et al., 2018; Yoder, 2014). We analyzed recombination in em-
bryos at E13.5, when LN anlagen formation had initiated and
before the dramatic expansion of the LN cluster because of lym-
photoxin signaling (Figures 1B and 1C). In the iCdh5tdT model,4OHT pulsing at E7.5 targets early YS he-
matopoiesis, resulting in efficient labeling
of microglia (Gentek et al., 2018; Hoeffel
et al., 2015; Zovein et al., 2008; Figure 5A).
When pulsed at E8.5, microglia progenitors
from the YS were still labeled. Also, at this
stage, LTi4 cells in the periphery and LTi-
like cells within the FL were labeled.
When 4OHTwas injected at E9.5, microglia
were hardly labeled at all, indicating that
YS contribution occurred until E8.5. LTi4
and LTi-like cells were still labeled very effi-
ciently at this stage, whereas 4OHT injec-
tions at E10.5 hardly labeled LTi or LTi-
like cells at all. These results would be in
line with embryonic LTi being generatedfrom late YS, early embryonic hematopoiesis, or a combination
thereof. To discriminate between YS or embryonic hemogenic
endothelial contributions, we used Cxcr4-CreERT2+/ ;RosatdT
(Werner et al., 2020) (hereafter referred to as iCxcr4tdT). Because
the YS endothelium does not express Cxcr4, this model labels
embryonic hemogenic endothelium-derived cells when pulsed
after E8 (McGrath et al., 1999; Park et al., 2018; Werner et al.,
2020). To confirm thatCxcr4 does not label YS-derived cells after
E8, we pulsed iCxcr4tdT at E8.5 and analyzed the embryo proper
and YS at E9.5. We observed that, within the YS, no cells ex-
pressed tdT, whereas, within the embryo proper, 20% ± 9.8%
of the total cell population was recombined (Figure S8D). In
line with this, 4OHT administration between E8 and E9 induced
only residual microglia labeling (Figure 5B), whereas we
observed about 63% recombination within the LTi population
using the same approach (Figure 5B). To confirm recombination
of LTi cells in situ within the LN anlagen, we analyzed sections
from iCdh5tdT and iCxcr4tdT embryos obtained from dams in-
jected with 4OHT between E8.5 and E10.5. Indeed, the presence
of tdTomato+CD4+ LTi4 cells within the LN anlagen followed the
results obtained by flow cytometry (Figure 5C). Collectively, the
fate mapping data from the iCdh5tdT or iCxcr4tdT modelsCell Reports 32, 108004, August 11, 2020 7
Figure 6. Embryonic LTi Cells Are Separate
from the HSC Wave but Replaced by HSCs
in Adults
(A) Recombination within microglia from the
brain (CD45+F4/80+), long-term HSCs (LT-HSCs;
defined as Lin–F4/80–CD45+CD11b–c-Kit+Sca-
1+CD48–CD150+), short-term HSCs (ST-HSCs;
defined as Lin–F4/80–CD45+CD11b–c-Kit+Sca-
1+CD48–CD150–), and multipotent progenitors
(MPPs; defined as Lin–F4/80–CD45+CD11b–c-
Kit+Sca-1–CD48+CD150–) from the FL and LTi4 cells
from the periphery from E13.5 iCdh5tdT embryos
pulsed at E8.5 or E10.5, measured by flow cy-
tometry.
(B) Microglia from the brain, LTi4 cells (CD45
+F4/
80–IL7Ra+a4b7
+CD4+) from the periphery, and LTi-
like cells (CD45+F4/80–IL7Ra+a4b7
+) from the FL
from E16.5 iCdh5tdT embryos pulsed at E8.5 or
E10.5, measured by flow cytometry.
(A and B) Data shown are from at least two
independent experiments and are shown as
average ± SD. Single data points represent individ-
ual embryos. See the flow cytometry strategies in
Figures S8A–S8C and S8E.
(C) Recombination of tdTomato in LTi4 cells (Lin
–C-
D45+IL7Ra+CD4+) from various adult iCdh5tdT
lymphoid organs and gut, pulsed with 4OHT at E8.5
and E10.5 and measured by flow cytometry. LN
AxBchIng is a pool of cells from the AxLNs, BrLNs,
and inguinal peripheral LNs. See the flow cytometry
strategies in Figures S9A–S9D.
See also Figures S9E and S9F. Each point repre-
sents an individual mouse. Data shown are from at
least 3 mice and shown as average ± SD.
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onic hematopoietic activity, most likely from the AGM region, but
not from YS hematopoiesis.
Layered Production of LTi Progenitors
Progenitors for, e.g., macrophages (Hoeffel et al., 2015), ILC2s
(Schneider et al., 2019), and mast cells (Gentek et al., 2018)
differentiated from distinct and developmentally restricted
HSCs. Therefore, we assessed whether LTi progenitor produc-
tion was distinct from that of adult-type definitive HSCs; i.e.,
those that colonize the bone marrow, where they ultimately
give rise to adult definitive hematopoietic lineages (Yoder,
2014). We compared the fate mapping kinetics of LTi progeni-
tors and FL HSCs in E13.5 embryos that had been pulsed at
E8.5 (the peak of LTi progenitor labeling) and at E10.5 (the
peak of HSC labeling; Yoder, 2014) using the iCdh5tdT model.
When 4OHT was injected at E8.5, we observed high LTi4
recombination, whereas the myeloid progenitor population8 Cell Reports 32, 108004, August 11, 2020(MPP) and long-term and short-term
HSCs were recombined at lower rates
(Figure 6A). Conversely, 4OHT injection
at E10.5 resulted in very low LTi recombi-
nation, whereas recombination in both
HSC populations was high (around 63%)
(Figures 5A and 6A). Recombination inMPPs was between HSC and LTi4 cells, indicating that they
were probably appearing before the HSC but after the LTi pop-
ulation (Figure 6A). We conclude that embryonic LTi progenitors
are produced prior to adult-type definitive HSCs.
It has been shown that, for ILC2s, different progenitors were
responsible for the different waves of ILC2 development during
late embryo gestation, neonatal life, and adulthood (Schneider
et al., 2019). A dramatic increase in LN anlagen size occurs after
E14.5,when the lymphotoxin pathway hasbeenactivated (vande
Pavert and Mebius, 2010). We reasoned that LTi cells involved
during initiation might be different and, thus, from a different he-
matopoietic wave than those during expansion and establish-
ment of the LN anlagen. We analyzed LTi recombination in
iCdh5tdT embryos at late gestation (E16.5), pulsed at E8.5 or
E10.5 (Figure 6B). The recombination rates followed those ob-
tainedwhen analyzed at E13.5. However, compared with periph-
eral LTi cells, we noted a slight increase in recombination of
CD45+F4/80–Il7Ra+a4b7
+ LTi-like cells in the FL when injected
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itorspresentwithin thispopulation at this stage.Weconclude that
all progenitors for embryonic LTi cells were efficiently labeled in
the embryonic hemogenic endothelium around E8.5 in the
iCdh5tdT model.
LTi cells have a half-life of 22–26 days (Sawa et al., 2010) and,
thus, need to be replaced during life, similarly as shown previ-
ously for ILC2s or mast cells (Gentek et al., 2018; Schneider
et al., 2019). To establish whether LTi cells derived from the
E8.5 embryonic wave are replaced in the adult by cells derived
from HSCs, we analyzed recombination in LTi4 cells within adult
iCdh5tdT lymphoid organs and gut when the mothers of these
mice were injected with 4OHT at E8.5 and E10.5. In these adult
mice, microglia behaved similarly as in the embryonic stages
analyzed (Figures 5A, 6C, and S9E). Definitive hematopoietic lin-
eages in adult blood were found to be recombined at lower rates
when 4OHTwas injected at E8.5 comparedwith E10.5, as shown
before (Gentek et al., 2018; Figure S9E). The HSCs in the bone
marrow followed the recombination rates observed for definitive
lineages (Figure S9F). For analysis of recombination in LTi4 cells,
we used several lymphoid organs. When 4OHT was injected at
E8.5, we observed that recombination was around 60% in all
LTi4 cells (Figure 6C), similar as for LTi cell recombination at em-
bryonic time points analyzed (Figures 5A and 6A). When 4OHT
was injected at E10.5, we also observed around 60% recombi-
nation in LTi4 cells in all lymphoid organs studied, which is similar
to definitive lineages and HSCs at this injection time point (Fig-
ure S9F) and much higher than when analyzed at E10.5 (Fig-
ure 6B). In summary, we observed high recombination in LTi cells
in embryos at E13.5 and E16.5 when 4OHT was injected only at
E8.5 but not when injected at E10.5 (Figures 6A and 6B).
Conversely, using the same approach, analysis of LTi cells in
adult lymphoid organs revealed that, when 4OHT was injected
at E10.5, high recombination was observed in these LTi cells
as well. Because the HSCs and definitive lineages were also
labeled at a similar percentage, these data suggest that Lti cells
in the adult are replaced by HSC-derived cells.
Collectively, iCdh5tdT and iCxcr4tdT fate mapping established
that embryonic LTi cells originate from early hematopoietic activ-
ity in embryonic hemogenic endothelial sites, independent of the
YS and independent of adult-type definitive hematopoiesis.
Similar to other innate immune lineages, such as macrophages
and mast cells (Gentek et al., 2018; Hoeffel et al., 2015), in the
adult, LTi cells are replaced by cells from definitive HSCs.
DISCUSSION
LTi cells are the first cells of the ILC family to appear during
embryogenesis and are essential for LN organogenesis. None-
theless, their precise ontogeny is not known. In this study, we
identified the kinetics of differentiation and the respective em-
bryonic locations.
Using 3D imaging of the complete embryo, we showed that
LTi0 and LTi4 cells aggregate at specific niches within the em-
bryo. This method allows better quantification compared with
flow cytometry because only cells within the cluster are counted
and not single cells situated outside of the LN anlagen, providing
accurate quantification of LTi cells associated with LN anlagen.Clustering occurred in a time-wise and anterior-to-posterior
patterning that followed the chronicity as was studied by block-
ing lymphotoxin signaling (Rennert et al., 1998). However, our
method is a refinement and enables much more comprehensive
identification of LN anlagen formation, well before lymphotoxin
signaling.
In LTi ontogeny, the known stages before LTi0 are the aLP or
LTiP stage and CLP stage (Ishizuka et al., 2016b, 2016a). To
establish the presence of the CLP and LTiP populations and
assess linear progress in LTi cell differentiation between FL
versus periphery, we thoroughly examined these populations in
both organs by flow cytometry and transcriptional profiling. We
first observed CLP and a few LTiP cells within the FL at E11.5
but no LTi0 nor LTi4 cells. CLPs were predominantly present
within the FL, whereas LTiP cells were equally present in the
FL and periphery. Based on these numbers and CLP plus LTiP
proliferation rates being especially high within the FL, we
conclude that, starting at the CLP stage and especially at LTiP
stages, the cells migrate out of the FL to the periphery, where
they are exposed to retinoic acid to induce RORgt (van de Pavert
et al., 2014). The transcriptional profile of the LTi0 stage, in which
Rorc is expressed, was associated with expression of retention
and transcription factors and thus established LTi cell identity
within the periphery. At later embryonic stages, most LTi0 and
LTi4 cells were present within the periphery, and hardly any
were observed within the FL, as confirmed by single-cell
sequencing. Transcriptional profiling revealed that the LTi0 and
LTi4 populations in the FL and periphery were remarkably similar;
thus, based on these data, we propose that LTi0 or LTi4 cells
within the periphery aremost likely not a progression in ontogeny
from the FL.
To obtain more insights in LTi cell ontogeny, we performed
RNA velocity analysis of the ILC population within the FL and
periphery. We were able to separate the aLP population from
the LTiPs and determined a hierarchical link between aLPs be-
ing mostly found in FL and LTiPs mostly observed within the
periphery. The LTi0 and LTi4 populations were mainly observed
within the periphery. This process of tissue-specific differentia-
tion within the embryo has been shown before for macro-
phages (Mass et al., 2016). Interestingly, we observed 2
different LTi4 populations, not discriminable by fluorescence-
activated cell sorting (FACS), based on MHC class II-associ-
ated genes for E13.5 and E14.5. It has been shown that
ILC3-like or LTi-like cells present MHC class II and have anti-
gen-presenting capabilities, especially within the gut (Hepworth
et al., 2013; Mackley et al., 2015), and we observed a diver-
gence already present at E13.5. Future studies should reveal
a difference in their LN-forming versus possible antigen-pre-
senting capacities.
The aLP population was highly dynamic and mainly gave rise
to LTiPs, LTi cells, and, to a lesser extent, ILC2, ILCp, and
ILC3 cells but not ILC1 cells at this embryonic stage. It is possible
that the same progenitors are able to divert into other ILCs at
other developmental stages when provided with the proper
external stimuli, as also shown before (Ishizuka et al., 2016b;
Koga et al., 2018).
Using an established Cdh5-CreERT2 and a Cxcr4-CreERT2
mouse lineage tracing model (Werner et al., 2020), we showedCell Reports 32, 108004, August 11, 2020 9
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embryonic hemogenic endothelial site but not from the YS he-
mogenic endothelium. The AGM region is the most-studied
and best-defined embryonic hemogenic endothelial site. Hemo-
genic endothelial sites have been observed outside of the AGM
region, like the head and heart, but most of the hematopoietic
clusters in these areas appeared later than the LTi progenitors
at E8.5 (Shigeta et al., 2019; Yzaguirre and Speck, 2016).
Notably, the vitelline artery, connected to the dorsal aorta in
the AGM, showed hematopoietic clusters (Yokomizo et al.,
2011; Yzaguirre and Speck, 2016; Zovein et al., 2010). Therefore,
we cannot exclude other embryonic hemogenic sites fromwhich
LTi progenitors could appear.
We confirmed that, at E9.5, the iCxcr4tdT model shows a
transient lower recombination efficiency (Werner et al., 2020)
compared with the iCdh5tdT model. Cxcr4 expression has
been shown to fluctuate within early hematopoiesis (Baron
et al., 2018), and, therefore, the lower efficiency in this model
at E9.5 could be due to transient lower Cxcr4 expression in
the embryonic hemogenic endothelium. Based on recombina-
tion in HSCs using the iCdh5tdT model, which started after
E10.5 and after appearance of LTi progenitors, we conclude
that the LTi progenitor wave is separated from the HSC
wave, making LTi progenitors one of the first lineages to appear
from the embryonic hemogenic endothelium. During adulthood,
LTi cells within lymphoid organs had similar recombination
rates as the definitive lineages and HSCs. Therefore, we
conclude that embryonic LTi cells are replaced in adulthood
by HSC-derived cells. It has been shown that embryonic LTi
and ILC3 cells have a half-life of around 24 days (Sawa et al.,
2010); thus, they are likely to be replaced starting around
2 weeks after birth, at a time when the definitive hematopoietic
lineages are starting to appear from the bone marrow (Gao
et al., 2018). Other members of the ILC family have been shown
to be derived from bone marrow HSCs; however, LTi cells
derived from bone marrow HSCs were not observed before
(Sawa et al., 2010; Schneider et al., 2019; Walker et al., 2019;
Xu et al., 2019). The functional difference between embryonic
and adult LTi cells is not known. Tertiary lymphoid formation
does not require LTi cells (Drayton et al., 2006), but a specific
role of LTi cells has been described in regeneration of the
spleen after inflammation (Scandella et al., 2008). Thus, the
main function of the embryonic LTi cells is to organize embry-
onic LN formation, whereas, in the adult, the role of LTi cells
is unclear.
In this study, we were able to pinpoint the release of the
earliest hematopoietic progenitor for an ILC-related lineage
from the embryonic hemogenic endothelium, most likely the
AGM region but not from the YS hemogenic endothelium and
separated from the definitive HSC wave. The model we used
will be of interest to other studies in which the specific contribu-
tion of embryonic hemogenic endothelial sites needs to be
analyzed to understand the highly organized release of hemato-
poietic progenitors in time and location. For the LTi ontogeny, we
propose that their hematopoietic progenitors arrive in the FL af-
ter E8.5 and differentiate toward the CLP stage. The subsequent
aLP/LTiP cells migrate from the FL, and aLPs preferentially
differentiate into LTi cells at E13.5, but to a much lesser extend10 Cell Reports 32, 108004, August 11, 2020than other ILC members at this embryonic stage. The FL could
already provide cues to skew progenitors toward a more LTi
phenotype, which is established by RORgt expression induced
within the periphery. It will be essential to understand which pro-
cesses occur in space and time and especially within the FL to
guide cell fate into LTi or other ILC lineages at later embryonic
stages and whether these embryonic ILCs will be replaced by
HSC-derived cells.STAR+METHODS
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Rat anti-mouse CD45 (clone 30-F11), BUV395 BD biosciences Cat#564279; RRID:AB_2651134
Rat anti-mouse CD45 (clone 30-F11), PeCy7 Ebioscience Cat#25-0451-82; RRID:AB_2734986
Rat anti-mouse F4/80 (clone T45-2342), BV510 BD biosciences Cat#743280; RRID:AB_2741398
Rat anti-mouse F4/80 (clone BM8), BV785 Biolegend Cat#BLE123141; RRID:AB_2563667
Rat anti-mouse F4/80 (clone T45-2342), PE-CF594 BD biosciences Cat#565613; RRID:AB_2734770
Rat anti-mouse CD11b (clone M1/70), FITC Ebioscience Cat#11-0112-85; RRID:AB_464936
Rat anti-mouse CD11b (clone M1/70), V500 BD biosciences Cat#562128; RRID:AB_10896991
Rat anti-mouse CD11b (clone M1/70), BV605 BD biosciences Cat#563015; RRID:AB_2737951
Rat anti-mouse IL7Ra (clone A7R34), eFluor 660 Ebioscience Cat#50-1271-80; RRID:AB_11218700
Rat anti-mouse CD4 (clone Gk1.5), PeCy7 Biolegend Cat#BLE100422; RRID:AB_312707
Rat anti-mouse CD4 (clone Gk1.5), unlabeled Ebioscience Cat#14-0041-82; RRID:AB_467063
Rat anti-mouse a4b7 (clone DATK32), BV786 BD biosciences Cat#740892; RRID:AB_2740540
Armenian hamster anti-mouse CD3e (clone 145-2C11),
Alexa Fluor 488
Ebioscience Cat#53-0031-82; RRID:AB_469889
Hamster anti-mouse CD3e (clone 145-2C11), BV510 BD biosciences Cat#563024; RRID:AB_2737959
Hamster anti-mouse CD3e (clone 145-2C11), PE-CF594 BD biosciences Cat#562286; RRID:AB_11153307
Rat anti-mouse CD19 (clone eBio1D3), FITC Ebioscience Cat#11-0193-82; RRID:AB_657666
Rat anti-mouse CD19 (clone 1D3), BV510 BD biosciences Cat#562956; RRID:AB_2737915
Rat anti-mouse CD19 (clone 1D3), PE-CF594 BD biosciences Cat#562291; RRID:AB_11154223
Rat anti-mouse CD8a (clone 53-6.7), V500 BD biosciences Cat#560776; RRID:AB_1937317
Rat anti-mouse CD8a (clone 53-6.7), PE-CF594 BD biosciences Cat#562283; RRID:AB_11152075
Rat anti-mouse B220 (clone RA3-6B2), Alexa Fluor 488 Ebioscience Cat#53-0452-82; RRID:AB_469907
Rat anti-mouse TER-119 (clone TER-119), FITC Ebioscience Cat#11-5921-82; RRID:AB_465311
Rat anti-mouse Ly-6G/Ly-6C (clone RB6-8C5), FITC Ebioscience Cat#11-5931-82; RRID:AB_465314
Rat anti-mouse Ly-6G (clone 1A8), BV510 Biolegend Cat#BLE127633; RRID:AB_2562937
Rat anti-mouse Ly-6G (clone 1A8), PE-CF594 BD biosciences Cat#562700; RRID:AB_2737730
Armenian hamster anti-mouse TCR b (clone H57-597), BV510 BD biosciences Cat#563221; RRID:AB_2738078
Rat anti-mouse CD115 (clone AFS98), PeCy7 Biolegend Cat#BLE135524; RRID:AB_2566460
Rat anti-mouse CD117 (‘c-Kit’)(clone 2B8), BV605 BD biosciences Cat#563146; RRID:AB_2738028
Hamster anti-mouse CD48 (clone HM48-1), BV711 BD biosciences Cat#740687; RRID:AB_2740373
Rat anti-mouse CD150 (clone TC15-12F12.2), PeCy7 Biolegend Cat#BLE115914; RRID:AB_439797
Rat anti-mouse Sca-1 (clone D7), APC Ebioscience Cat#17-5981-82; RRID:AB_469487
Rat anti-mouse CD31 (clone 390), PerCP-eFluor710 Ebioscience Cat#46-0311-80; RRID:AB_1834430
Mouse anti-mouse Tubulin beta-3 (clone TUJ1),
Alexa Fluor 488
Biolegend Cat#BLE801203; RRID:AB_2564757
Chicken anti-GFP, unlabeled AVES Cat#GFP-1020; RRID:AB_10000240
Donkey anti-rat, Alexa Fluor 488 Thermo fisher Cat#A-21208; RRID:AB_2535794
Donkey anti-chicken, Cy3 Jackson immunoresearch Cat#703-166-155; RRID:AB_2340364
Donkey anti-rat, Alexa 647 Jackson immunoresearch Cat#712-605-153; RRID:AB_2340694
Biological Samples
Normal Mouse Serum Jackson Immunoresearch Cat#015-000-120; RRID:AB_2337194
Normal Donkey Serum Jackson Immunoresearch Cat#017-000-121; RRID:AB_2337258
Fetal Bovine Serum Sigma-Aldrich Cat#F7524-500mL
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Chemicals, Peptides, and Recombinant Proteins
4-Hydroxytamoxifen Sigma-Aldrich Cat#T176-50mg
Progesterone Sigma-Aldrich Cat#P0130-25mg
Peanut oil Sigma-Aldrich Cat#P2144-250mL
Liberase TM Roche Cat#05401127001
DNase I Roche Cat#11284932001
Collagenase from Clostridium histolyticum Sigma-Aldrich Cat#C2139-100mg
Percoll Sigma-Aldrich Cat#GE17-0891-02
CD45 MicroBeads, mouse Miltenyi Cat#130052301
SYTOX Blue Dead Cell Stain Invitrogen Cat#S34857
Zombie UV Fixable Viability dye Biolegend Cat#BLE423108
eBioscience 1X RBC Lysis Buffer Ebioscience Cat# 00-4333-57
FACS buffer Homemade N/A
HEPES GIBCO Cat#15630-80
UltraPure EDTA Invitrogen Cat#15576-028
Buffer A Homemade N/A
Buffer B Homemade N/A
PBS Homemade N/A
Acetone Carlo Erba chemicals Cat#301505
Methanol Carlo Erba chemicals Cat#412383
Benzyl alcohol Honeywell Cat#108006
Benzyl benzoate Acros organics Cat#105862500
Mowiol 4-88 Calbiochem Cat#475904
Sucrose Sigma-Aldrich Cat#S9378
16% Paraformaldehyde solution Delta microscopies Cat#D15710
BSA ID bio Cat#1000-70
Triton X-100 Sigma-Aldrich Cat#T8787-250mL
PBS-MT Homemade N/A
BABB Homemade N/A
Critical Commercial Assays
Click-iT Plus Edu Alexa Fluor 594 Flow Cytometry Assay Kit Invitrogen Cat#C10646
Adult Brain Dissociation kit, mouse and rat Miltenyi Cat#130-107-677
Chromium Single Cell 30 Library and Gel Bead Kit v2, 4 rxns 10x Genomics Cat#120267
Chromium i7 Multiplex Kit, 96 rxns 10x Genomics Cat#120262
Chromium Single Cell 30 GEM, Library & Gel Bead Kit v3,
4 rxns
10x Genomics Cat#1000092
SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing Clontech Cat#634888
Agilent RNA 6000 Pico Kit Agilent Cat#5067-1513
High Sensitivity DNA Analysis Kit Agilent Cat#5067-4626
Qubit dsDNA HS Assay Kit ThermoFisher Cat#Q32854
Single cell RNA purification kit Norgen Biotek Corp. Cat#51800
Deposited Data
Raw data This paper GEO: GSE153771
Analyzed sequencing data This paper https://github.com/CIML-bioinformatic/
SPlab_BecomingLTi
Experimental Models: Organisms/Strains
Mouse: C57BL/6J (JAX mice strain) Charles River Stock#632
Mouse: RjOrl:SWISS (‘CD1’) Janvier Labs https://www.janvier-labs.com/en/
fiche_produit/swiss_mouse/
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Mouse: RORgteGFP Sparwasser et al., 2004 Gift from Ge´rard Eberl
Mouse: Cdh5-CreERT2+/ So¨rensen et al., 2009 Gift from Ralf Adams
Mouse: Cxcr4-CreER+/ Werner et al., 2020 N/A
Mouse: RosatdTomato/ tdTomato Madisen et al., 2010; The
Jackson Laboratory
Stock# 007914
Software and Algorithms
FlowJo version 10.5.3 FlowJo, LLC https://www.flowjo.com/
Prism version 8.3.0 GraphPad Software, LLC https://www.graphpad.com/
ImageJ 1.52p Wayne Rasband NIH, USA https://imagej.nih.gov/ij/
IMARIS version 9.1.2 Bitplane https://imaris.oxinst.com/
Phototshop, CC2015 Adobe https://www.adobe.com
Cell Ranger v3 10X Genomics https://support.10xgenomics.com
R v3.6 & v3.4 The R Project https://www.r-project.org
Docker v19 Docker https://www.docker.com/
Singularity v2.6 Singularity https://singularity.lbl.gov/
Snakemake v5.13 Snakemake https://snakemake.readthedocs.io/
en/stable/
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Lead Contact
Further information and requests for resources and reagents should be directed to Serge A. van de Pavert (vandepavert@ciml.
univ-mrs.fr).
Materials Availability
This study did not generate new unique reagents.
Data and Code Availability
Sequencing data and codes were deposited in online databases. All RNA-sequencing data were deposited in the Gene Expression
Omnibus public database as superseries under GSE153771. In-house-made code, original data, and corresponding docker images
are available from the project github repository (https://github.com/CIML-bioinformatic/SPlab_BecomingLTi) both with a readme ex-
plaining the detailed procedure to reproduce the results.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
Mice were maintained under specific pathogen free and a 12h light and dark cycle at an ambient temperature of 22C in the animal
facilities of the CIML (Marseille, France). Animals were housed in individually ventilated cages containing sterile quarter-inch corncob
bedding for environmental enrichment. They were fed with irradiated standard pellet chow and reverse osmosis water. All experi-
ments were performed according to the French ethics committee regulations. C57BL/6J and CD1 female and male mice were pur-
chased from Charles River and Janvier Labs respectively. RORgteGFP mice were kindly provided by Ge´rard Eberl (Pasteur Institute,
Paris, France) (Sparwasser et al., 2004). Cdh5-CreERT2+/ mice were kindly provided by Ralf Adams (Max Planck Institute for Mo-
lecular Biomedicine, M€unster, Germany) (So¨rensen et al., 2009). Cxcr4-CreERT2+/ (Werner et al., 2020) and the previously
mentioned Cdh5-CreERT2+/ lines were crossed to homozygosity for the tdTomato reporter sequence using RosatdTomato/ tdTomato
(Rosa
tdT/tdT
) (Madisen et al., 2010) mice and will be later referred to as iCxcr4tdT and iCdh5tdT respectively. Unless stated otherwise,
female mice were used between 7 and 15 weeks of age and males were between 8 and 20 weeks of age. Analyzed embryos and
adult mice included both females and males.
METHOD DETAILS
Timed pregnancies and Tamoxifen administration
For fatemapping of Lymphoid Tissue inducer (LTi) cells, iCdh5tdT and iCxcr4tdT male mice were crossed with C57BL/6J
females. For induction of reporter recombination in the offspring, pregnant females were administered intraperitoneally 1.2mg ofCell Reports 32, 108004, August 11, 2020 e3
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OPEN ACCESS4-hydroxytamoxifen (4OHT – Sigma T176) and 0.6mg of progesterone (Sigma P0130) at different embryonic stages (from E7.5 to
E10.5). For adult fatemapping experiments, pups were delivered by C section and cross fostered with lactating CD1 females. For
lymph node (LN) formation analysis, EdU experiment and bulk sequencing, male RORgteGFP mice were crossed with C57BL/6J
female mice. For single cell sequencing, C57BL/6J male mice were crossed with C57BL/6J females. Mice were mated overnight,
and the day of vaginal plug detection was marked as E0.5. Littermate embryos that were scored younger upon isolation were dis-
carded from analysis.
Flow-cytometry
Embryos
iCxcr4tdT embryos pulsed with 4OHT at E8.5 and collected at E9.5 were isolated. Embryos were carefully separated from the yolk sac
and both tissues were analyzed for expression of Cxcr4 by tdTomato by flow-cytometry in endothelial cells stained with CD31 (Ebio-
science 46-0311-80). Tissues were gently digested using liberase TM and DNaseI enzymes (Sigma-Aldrich 5401127001 and
11284932001 respectively) for 20min at 37C under agitation as performed before (van de Pavert et al., 2014). After digestion cells
were washed with RPMI 2% FBS (Sigma-Aldrich F7524), centrifugated (1250rpm at 4C for 7 min) and resuspended. RORgteGFP em-
bryos were collected between embryonic days E11.5-E14.5 and 4OHT pulsed iCdh5tdT or iCxcr4tdT embryos were collected at E13.5
or E16.5. Fetal livers (FL) were dissected from embryos and isolated for analysis of LTi cells. Brains of fate mapped embryos were
isolated for analysis of tdTomato recombination in microglia. Limbs and all internal organs were removed to enrich for peripheral LN
anlagen (except for E11.5RORgteGFP embryos being too premature to remove all organs) and checked for LTi cells. This tissue is later
mentioned as periphery. Tissues were gently digested as described above. Cells were blocked (15% normal mouse serum (Jackson
Immunoresearch 015-000-120), in FACS buffer (HBSS 2% FBS)) for 15 min and subsequently stained for CD45 (BD biosciences
564279), F4/80 (BD biosciences 743280), CD11b (Ebioscience 11-0112-85), IL7Ra (Ebiocience 50-1271-80), CD4 (Biolegend
BLE100422), a4b7 (BD biosciences 740892) diluted in FACS buffer for 30min on ice. Cells were washed with FACS buffer and resus-
pended in Sytox Blue (Invitrogen s34857) diluted in FACS buffer after centrifugation (1250rpm at 4C for 7 min). The liver of a few
pulsed iCdh5tdT embryos at E8.5 or E10.5 collected at E13.5 were stained for hematopoietic stem cells (HSC) progenitors using
CD45, CD3e (Ebioscience 53-0031-82), CD19 (Ebioscience 11-0193-82), B220 (Ebioscience 53-0452-82), TER-119 (Ebioscience
11-5921-82), Ly6G (Ebioscience 11-5931-82), CD11b (BD biosciences 562128), CD117 (BD biosciences 563146), CD48 (BD biosci-
ences 740687), F4/80 (Biolegend BLE123141), CD150 (Biolegend BLE115914), Sca1 (Ebioscience 17-5981-82) and zombie UV (Bio-
legend BLE423108). The staining of dead cells with zombie UVwas performed for another 30min after the antibody staining in protein
free HBSS right after washing the cells. Cells were subsequently washed and resuspended in FACS buffer.
Adult mice
4OHT iCdh5tdT mice pulsed at E8.5 or E10.5 were sacrificed between 7 and 9 weeks of age. Blood samples were drawn from the
retro-orbital vein prior to sacrifice and subjected to red blood lysis prior to staining using RBC lysis buffer (eBioscience 00-4333-
57). Brain, bone marrow, spleen, gut, cervical (C), mandibular (Md), mesenteric (M), axillary (Ax), brachial (Br) and inguinal lymph no-
des (IngLN) were collected. The three latter mentioned LNs were pooled and referred to as AxBrIngLN on the graphs. Soft tissues
including spleens, LNs and bone marrows (after the cells have been flushed from the bones) were gently digested as described pre-
viously. Red blood cell lysis was also performed on spleen and bone marrow samples prior to staining. Brains were prepared using
the brain dissociation kit from Miltenyi (Miltenyi Biotec 130-107-677). Guts were prepared as described previously (Rankin et al.,
2016). Briefly, small intestine was harvested and Peyer patches were removed as well as all the fat and faces. After cutting it longi-
tudinally, 2-3cm long fragments were cut and placed in PBS. Pieces were then incubated for 30min at 37C under agitation (200rpm)
in 20mL buffer A (HEPES 1M (GIBCO 15630-80), EDTA (Invitrogen 15576-028) 0.5M, 10% FBS in PBS). EDTA was washed 4 times
with PBS and scissor minced pieces were incubated for 55 min at 37C under agitation (200rpm) in 20mL buffer B (HEPES 1M, 10%
FBS, 6000UI Collagenase (Sigma-Aldrich C2139) in RPMI). Remaining aggregates were mechanically disrupted using a syringe and
cells were filtered over a 70mmcell strainer and washed with RMPI 10%FBS. After centrifugation (1500rpm at room temperature (RT)
for 10 min), cells were resuspended in 5mL 100% Percoll (Sigma-Aldrich GE17-0891-02) and placed at the bottom of 5mL of 40%
Percoll. Cells were centrifuged for 20min without break (2100rpm at RT) andmiddle ring cells were harvested and washed with RPMI
10% FBS. Spleen, gut and LN samples were stained for CD45, CD11b (BD biosciences 563015), F4/80, CD3e (Ebiosciences 47-
0031-80), CD19 (BD biosciences 562956), CD8a (BD biosciences 560776), Ly6G (Biolegend BLE127633), TCRb (BD biosciences
563221), IL7Ra, a4b7, CD4 and zombie UV. Blood samples were stained for CD45 (Ebiosciences 25-0451-82), CD3e, CD19,
CD11b and Zombie UV. Bone marrows were stained for HSC progenitors as described previously. Brain samples were stained
for CD45, CD11b, CD115 (Biolegend BLE135524), F4/80 and Sytox Blue. Samples were acquired on the LSRFortessa-X20 (BD Bio-
sciences) cytometer and data were analyzed using FlowJo (version 10, LLC) software.
Immunofluorescence
4OHT pulsed iCdh5tdT or iCxcr4tdT embryos were collected at E13.5. Embryos were fixed by immersion in 4% paraformaldehyde
(PFA - Electron Microscopy Science, ref 15714) for 30 min at RT, subsequently cryoprotected with 10% sucrose (Sigma-Aldrich
S9378) and 30%sucrose in PBS overnight, frozen inOCT and 20mmcryosections were cut. Sections were first dehydrated in acetone
(Carlo Erba chemicals 301505) for 10 min and after rehydratation in PBS, they were blocked (15% normal donkey serum (NDS, Jack-
son Immunoresearch 017-000-121), 2% BSA (ID bio 1000-70) in PBS) for 15 min and incubated with rat anti-CD4 (clone GK1.5,e4 Cell Reports 32, 108004, August 11, 2020
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incubated with donkey anti-rat Alexa Fluor 488 (ThermoFisher A-21208) for 45min at RT, washed with PBS andmountedwithMowiol
4-88 (Calbiochem 475904) plus 1,4-diazabicyclo[2.2.2]octane (Sigma-Aldrich D27802) mounting solution. Images were acquired us-
ing Zeiss LSM 780 and 880 confocal laser scanning microscopes and analyzed using Fiji software.
Whole mount preparation and analysis
E11.5, E12.5, E13.5 or E14.5 RORgteGFP embryos were fixed in 0.4% PFA overnight at 4C and subsequently placed in blocking me-
dium (PBS-MT (1% skim milk, 0.4% Triton X-100 in PBS), 5% NDS) for three days. Embryos were incubated with anti-GFP (AVES,
GFP-1020) and rat anti-CD4 in PBS-MT + 3% NDS for 7 nights and after washing with PBS + 0.2% Triton X-100 incubated with
donkey anti-chicken Cy3 (Jackson Immunoresearch 703-166-155) and donkey anti-rat Alexa 647 (Jackson Immunoresearch 712-
605-153) and bIII-tubulin Alexa 488 (Biolegend, 801203) in PBS-MT + 3% NMS for another 7 nights. Embryos were first washed
with PBS + 0.2% Triton X-100 and dehydrated using methanol (Carlo Erba chemicals 412383) series (20%, 40%, 60%, 80% and
100%1h each and 100%ON) and cleared using a 1:1mixture of methanol and BABB (2:1 benzyl alcohol (Honeywell 108006) / benzyl
benzoate (Acros organics 105862500)) for 8h. Clearing was completed by incubating embryos in BABB until acquisition. Embryos
were acquired using the light sheet Ultramicroscope version II (LaVision BioTec).
EdU proliferation assay
Dams carrying RORgteGFP embryos were injected 2h prior isolation with 100mg/g of body weight EdU (Life technologies, C10646).
Embryos were collected at E13.5 and FL and periphery were prepared as described before. Cells were first stained for CD45, F4/
80, IL7Ra, a4b7 and zombie UV. Then cells were fixed and permeabilized to stain for intracellular EdU following the protocol of
the Click-it Plus EdU Flow-cytometry Assay Kit (Life technologies, C10646). Cells were subsequently analyzed by Flow-cytometry.
Next generation sequencing
For the bulk RNA sequencing, RORgteGFP E13.5 embryos were isolated and both FL or the embryonic periphery, enriched for periph-
eral LN anlagen and thus without thymus, gut or other organs were dissociated using the above-mentioned protocol. CD45+ cells
were enriched using CD45 magnetic microbeads (Miltenyi Biotec 130052301) on the autoMACS Pro separator. A lineage cocktail
was used for removing possible T, B, dendritic cells and macrophages (CD3e (BD biosciences 562286), CD19 (BD biosciences
562291), CD8a (BD biosciences 562283), Ly6G (BD biosciences 562700), F4/80 (BD biosciences 565613)). Cells were subsequently
stained and the common lymphoid progenitor (CLP) (alive Lin–CD45+IL7Ra+a4b7
–RORgt–CD4–), LTi progenitor (alive Lin–CD45+
IL7Ra+a4b7
+RORgt–CD4–), LTi0 (alive Lin
–CD45+IL7Ra+a4b7
+RORgt+CD4–) and LTi4 (alive Lin
–CD45+IL7Ra+a4b7
+RORgt+CD4+) cells
were sort-purified using the BD FACS ARIA III sorter. RNA was isolated using a RNA purification kit (Norgen Biotek Corp. 51800) and
the quality and concentration of the RNAwas determined with the bioanalyzer using RNA 6000 pico kit (Agilent 5067-1513) and Qubit
fluorometer (ThermoFisher) using the Qubit dsDNAHS Assay Kit (ThermoFisher Q32854). Only those samples with a RIN value above
8 were used for subsequent library preparation. Samples were pre-amplified with the SMART-Seq v4 Ultra Low Input RNA Kit (Clon-
tech). Libraries were generated with sample barcode and molecular indexing, the latter being used in order to provide an absolute
digital measurement of gene expression levels. Sequencing was performed using a NextSeq 500, in 2 runs of 14 muLTiPlexed sam-
ples. NextSeq 500 data were demuLTiPlexed individually per sample. Furthermore, the raw fastq files were processed to trim the
molecular barcodes, the end of reads depending on quality, and the potential remaining illumina adapters. A sequencingQuality Con-
trol (QC) step was run twice on the fastq file: before and after the trimming of the reads. Afterward, alignments were performed using
STAR versus GRCm38 ensemble transcriptome resulting in a BAM which was qualified by Qualimap RNaseq. Detection and elim-
ination of duplicated reads were done using MarkDuplicates. Finally, one table count by run was obtained using FeatureCount. Bio-
informatics analysis were done in R using house made scripts. Normalization of counts and detection of differentially expressed
genes was done using DEseq2 R package, PCA was done using the ade4 R package.
For the single cell sequencing C57BL/6J E13.5 and E14.5 embryonic peripheries and FL were collected and cell suspension were
prepared as mentioned above. CD45+ cells were enriched using CD45 magnetic microbeads on the autoMACS Pro separator. Cells
were subsequently stained and alive CD45+ F4/80- IL7Ra+ LTi cells were sort-purified using the BD FACS ARIA III sorter. Sorted-pu-
rified cells were subsequently prepared for single-cell sequencing using the Chromium Single Cell 30 kit from 10X genomics (v2 for
periphery and v3 for FL (120267 and 1000092 respectively– California, USA) for the library preparation and the NextSeq 500/550 High
Output Kit v2 (75 cycles) cartridges from Illumina for the sequencing. The quality and concentration of the cDNAwas determined with
the bioanalyzer using the High Sensitivity DNA Analysis Kit (Agilent 5067-4626) and Qubit fluorometer using the Qubit dsDNA HS
Assay Kit. FASTQ raw files were processed using Cell Ranger software (v3, default parameters), which performs alignment, filtering,
barcode counting and unique molecular identifier (UMI) counting. Reads were aligned to the mouse mm10 genome.
Quality control and cell filtering: Quality control (QC) was performed to remove poor quality cells thanks to in-house developed R
scripts. Using Seurat R package CreateSeuratObject function, cells with less than 200 or more than 5000 (potential doublets) de-
tected genes, cells with a too low or too high number of UMI (nUMI < median - 3MAD or nUMI > media + 3MAD) and cells with
more than 40%mitochondrial gene expression (apoptotic cells) were removed. After quality control, for E13.5 FL 248 cells were taken
out, leaving 10533 for analysis; for E13.5 periphery, 322 cells were taken out, leaving 4209 for analysis; for E14.5 FL, 678 cells were
taken out, leaving 11410 for analysis; for E14.5 periphery 707 cells were taken out, leaving 4301 for analysis. Expression data wereCell Reports 32, 108004, August 11, 2020 e5
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OPEN ACCESSnormalized using the Seurat R package NormalizeData function (using logNormalize method and scale factor of 10000). Using PCA
(see below), we observed a dependency in number of UMI in the first principal component. We centered and regressed the expres-
sion data from that factor using the Seurat R package ScaleData function (centering true and scaling false). Using Seurat clustering
method, we observed several clusters expressing genes identified as contaminating cells.
Dimensionality reduction and clustering: we ran principal-components analysis (PCA) using the dudi.pca function from ade4 R
package with data centering. We ran t-distributed stochastic neighbor embedding (t-SNE) implemented via Barnes-Hut approxima-
tions (bh-SNE), using the Rtsne function fromRtsne R package (perplexity = 30, and default option values). Clustering was done using
two methods: (i) Seurat FindClusters based on PCA dimensionality reduction and the 10 first principal components; (ii) getKnnClus-
ters function from Pagoda2 R package taking advantage of theMultilevel community detection method (Velocyto results; see below).
RNA velocity analysis
Single-cell RNA velocity analysis was done using the velocyto tool in two steps. First, we used the python implementation with the
velocyto run CLI to produce a loom file with the model computation (see http://velocyto.org/velocyto.py/tutorial/cli.
html#running-velocyto). Then, we used the velocyto and Pagoda2 R packages both with in-house developed scripts to produce
further analysis from the obtained loom file, following Kharchenko Lab documentation (see http://pklab.med.harvard.edu/
velocyto/notebooks/R/DG1.nb.html). Cell velocity flow was mapped on the t-SNE map produced at the previous steps using the
show.velocity.on.embedding.cor function of the velocyto R package.
QUANTIFICATION AND STATISTICAL ANALYSIS
Quantification of LN formation
LN size was analyzed by counting the number of CD4+ andGFP+ cells at the right sides of the E11.5, E12.5, E13.5 or E14.5RORgteGFP
embryo using IMARIS software (version 9.1.2, Bitplane). CLN, MdLN, AxLN, BrLN, RenLN, IngLN and PopLN anlagen were analyzed.
Statistical analysis
Graphs, average values and standard deviation (SD) shown in all figures were calculated using Prism (version 8.3.0 GraphPad soft-
ware) software. The number of individual experiments can be found in the legends of all the figures. Photoshop software (CC2015,
Adobe) was used to generate figures.e6 Cell Reports 32, 108004, August 11, 2020
